AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a ...

Apple reported strong quarterly revenue as iPhone demand surged, but questions remain around AI strategy, rising costs, and leadership changes. If you can only read one tech story a day, this is it.